日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A mechanism-based pharmacokinetic/pharmacodynamic analysis of polymyxin B-based combination therapy against carbapenem-resistant Klebsiella pneumoniae isolates with diverse phenotypic and genotypic resistance mechanisms

基于机制的药代动力学/药效学分析:以多粘菌素B为基础的联合疗法对抗具有不同表型和基因型耐药机制的碳青霉烯类耐药肺炎克雷伯菌分离株。

Mahadevan, Ramya; Garcia, Estefany; Sharma, Rajnikant; Qiu, Hongqiang; Elsheikh, Ahmed; Parambi, Robert; Abboud, Cely Saad; Pasteran, Fernando; Ramirez, Maria Soledad; Kaye, Keith S; Bonomo, Robert A; Rao, Gauri G

Hydrazone-based photocages for precise sub-organelle visualization and drug release.

基于腙的光笼用于精确的亚细胞器可视化和药物释放

Wang Xia, Zhou Jingming, Cheng Yu, Wu Hongmei, Su Xuejing, Wang Rundong, Xiao Kaiyan, Zhang Weiwei, Chen Zhong, Xu Bing, Lu Yusheng, Qiu Hongqiang, Xie Lijun

Population pharmacokinetics study on nebulized and intravenous administration of polymyxin B in patients with pneumonia caused by multidrug-resistant gram-negative bacteria

一项关于雾化和静脉注射多粘菌素B治疗多重耐药革兰氏阴性菌肺炎患者的群体药代动力学研究

Li, Xueyong; Zhou, Lili; Wang, Danjie; Wu, Qiong; Huang, Xuanxi; Zhang, Hui; Wu, Wenwei; Liu, Maobai; Wu, Xuemei; Qiu, Hongqiang; Cheng, Yu

Population pharmacokinetics and Monte Carlo-based dosing optimization of trimethoprim-sulfamethoxazole

甲氧苄啶-磺胺甲噁唑的群体药代动力学和基于蒙特卡罗方法的剂量优化

Chen, Bo; Chen, Yiying; Chen, Ming; Mao, Yunyi; Huang, Yingbin; Zhou, Lili; Wu, Wenwei; Li, Xueyong; Wu, Xuemei; Cheng, Yu; Qiu, Hongqiang

The relationship between the alveolar epithelial lining fluid concentration of intravenous plus inhaled polymyxin B and clinical efficacy in patients with pneumonia caused by carbapenem-resistant gram-negative bacilli: a prospective cohort study

静脉注射加吸入多粘菌素B与碳青霉烯耐药革兰氏阴性杆菌肺炎患者肺泡上皮衬液浓度的关系:一项前瞻性队列研究

Zhou, Lili; Wang, Danjie; Li, Xueyong; Cheng, Yu; Lin, Yiqin; Weng, Qinyong; Wu, Wenwei; Huang, Xuanxi; Qiu, Hongqiang; Zhang, Hui

Population Pharmacokinetics-Based Evaluation of Ceftazidime-Avibactam Dosing Regimens in Critically and Non-Critically Ill Patients With Carbapenem-Resistant Klebsiella pneumoniae

基于群体药代动力学的头孢他啶-阿维巴坦给药方案在重症和非重症碳青霉烯耐药肺炎克雷伯菌患者中的评价

Chen, Yiying; Chen, Bo; Huang, Yingbin; Li, Xueyong; Wu, Junnan; Lin, Rongqi; Chen, Ming; Liu, Maobai; Qiu, Hongqiang; Cheng, Yu

The impact of dose and discontinuation timing of preoperative ACE inhibitors on survival outcomes in cardiac surgery: A MIMIC-IV database analysis

术前使用ACE抑制剂的剂量和停药时间对心脏手术患者生存结局的影响:一项基于MIMIC-IV数据库的分析

Zou, Xiu; Chen, Shengyang; Hu, Lingyan; Sha, Lan; Zhou, Jianxing; Qiu, Hongqiang; Wu, Xuemei

Saliva as a TDM Matrix and Its Application in the Model-Informed Precision Dosing

唾液作为治疗药物监测基质及其在模型指导下的精准给药中的应用

Xu, Baohua; Wen, Yujie; Lu, Jinxia; Liu, Maobai; Luo, Xin; Huang, Wei; Xie, Helin; Cheng, Yu; Qiu, Hongqiang; Wu, Xuemei

Chinese consensus guidelines for therapeutic drug monitoring of polymyxin B, endorsed by the Infection and Chemotherapy Committee of the Shanghai Medical Association and the Therapeutic Drug Monitoring Committee of the Chinese Pharmacological Society

由上海市医学会感染与化疗委员会和中国药理学会治疗药物监测委员会共同认可的《多粘菌素B治疗药物监测中国共识指南》。

Liu, Xiaofen; Huang, Chenrong; Bergen, Phillip J; Li, Jian; Zhang, Jingjing; Chen, Yijian; Chen, Yongchuan; Guo, Beining; Hu, Fupin; Hu, Jinfang; Hu, Linlin; Li, Xin; Qiu, Hongqiang; Shao, Hua; Sun, Tongwen; Wang, Yu; Xu, Ping; Yang, Jing; Yang, Yong; Yu, Zhenwei; Zhang, Bikui; Zhu, Huaijun; Zuo, Xiaocong; Zhang, Yi; Miao, Liyan; Zhang, Jing

Evaluation and Validation of the Limited Sampling Strategy of Polymyxin B in Patients with Multidrug-Resistant Gram-Negative Infection

对多重耐药革兰氏阴性菌感染患者进行多粘菌素B有限采样策略的评价与验证

Li, Xueyong; Zhang, Bingqing; Cheng, Yu; Chen, Maohua; Lin, Hailing; Huang, Binglin; Que, Wancai; Liu, Maobai; Zhou, Lili; Weng, Qinyong; Zhang, Hui; Qiu, Hongqiang